StonvexLoading…
StonvexStonvexStonvexCore line items from SWKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Q1 2026 2026-01-02 | Annual 2025 2025-10-03 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $1.98B | $1.04B | $4.09B | $2.99B |
Operating Income | $145.90M | $103.80M | $500.00M | $389.00M |
Net Income | $114.80M | $79.20M | $477.10M | $335.70M |
EPS (Diluted) | $0.76 | $0.53 | $3.08 | $2.14 |
Total Assets | $7.90B | $7.87B | $7.92B | $7.71B |
Total Liabilities | $2.13B | $2.11B | $2.16B | $2.06B |
Cash & Equivalents | $1.41B | $1.55B | $1.16B | $1.19B |
Free Cash Flow OCF − CapEx | $306.90M | $339.00M | $1.11B | $961.80M |
Shares Outstanding | 150.40M | 149.90M | 148.70M | 148.40M |